Eligibility Heart Disease NCT00121550

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients aged 18 to 85 years and
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
previous acute myocardial infarction (ami) or
Description

myocardial infarction

Data type

boolean

Alias
UMLS CUI [1]
C0027051
previous or present angina pectoris and
Description

angina pectoris

Data type

boolean

Alias
UMLS CUI [1]
C0002962
signed informed concent
Description

informed concent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
ami or unstable angina pectoris within the last three months
Description

ami or unstable angina pectoris within the last three months

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002965
revascularisation (ptca or cabg) within the preceding six months
Description

revascularisation

Data type

boolean

Alias
UMLS CUI [1]
C2936173
UMLS CUI [2]
C0010055
severe heart failure (new york heart association (nyha) functional class iv)
Description

heart failure

Data type

boolean

Alias
UMLS CUI [1]
C1275491
known impaired renal or hepatic function
Description

known impaired renal or hepatic function

Data type

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0232741
active malignancy
Description

malignancy

Data type

boolean

Alias
UMLS CUI [1]
C0006826
intolerance to macrolides
Description

intolerance to macrolides

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003240
treatment with methylxanthines, carbamazepine, cisapride, astemizole, terfenadine, or coumarin anticoagulants
Description

treatment with methylxanthines, carbamazepine, cisapride, astemizole, terfenadine, or coumarin anticoagulants

Data type

boolean

Alias
UMLS CUI [1]
C0066447
UMLS CUI [2]
C0006949
UMLS CUI [3]
C0072916
UMLS CUI [4]
C0085170
UMLS CUI [5]
C0085173
UMLS CUI [6]
C0010206
earlier inclusion in the claricor trial or participation in another drug trial within four weeks
Description

earlier inclusion in the claricor trial or participation in another drug trial within four weeks

Data type

boolean

Alias
UMLS CUI [1]
C2348568
participation in other clinical trials within one month before this trial
Description

participation in other clinical trials within one month before this trial

Data type

boolean

Alias
UMLS CUI [1]
C2348568
individuals incapable of managing own affairs or not able to sign written consent
Description

individuals incapable of managing own affairs or not able to sign written consent

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
lack of written consent
Description

lack of written consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
women of childbearing age not using reliable contraceptives
Description

women of childbearing age not using reliable contraceptives

Data type

boolean

Alias
UMLS CUI [1]
C0009871
breast feeding women
Description

breast feeding women

Data type

boolean

Alias
UMLS CUI [1]
C0006147

Similar models

Eligibility Heart Disease NCT00121550

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
patients aged 18 to 85 years and
boolean
C0001779 (UMLS CUI [1])
myocardial infarction
Item
previous acute myocardial infarction (ami) or
boolean
C0027051 (UMLS CUI [1])
angina pectoris
Item
previous or present angina pectoris and
boolean
C0002962 (UMLS CUI [1])
informed concent
Item
signed informed concent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ami or unstable angina pectoris within the last three months
Item
ami or unstable angina pectoris within the last three months
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
revascularisation
Item
revascularisation (ptca or cabg) within the preceding six months
boolean
C2936173 (UMLS CUI [1])
C0010055 (UMLS CUI [2])
heart failure
Item
severe heart failure (new york heart association (nyha) functional class iv)
boolean
C1275491 (UMLS CUI [1])
known impaired renal or hepatic function
Item
known impaired renal or hepatic function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
malignancy
Item
active malignancy
boolean
C0006826 (UMLS CUI [1])
intolerance to macrolides
Item
intolerance to macrolides
boolean
C0020517 (UMLS CUI [1,1])
C0003240 (UMLS CUI [1,2])
treatment with methylxanthines, carbamazepine, cisapride, astemizole, terfenadine, or coumarin anticoagulants
Item
treatment with methylxanthines, carbamazepine, cisapride, astemizole, terfenadine, or coumarin anticoagulants
boolean
C0066447 (UMLS CUI [1])
C0006949 (UMLS CUI [2])
C0072916 (UMLS CUI [3])
C0085170 (UMLS CUI [4])
C0085173 (UMLS CUI [5])
C0010206 (UMLS CUI [6])
earlier inclusion in the claricor trial or participation in another drug trial within four weeks
Item
earlier inclusion in the claricor trial or participation in another drug trial within four weeks
boolean
C2348568 (UMLS CUI [1])
participation in other clinical trials within one month before this trial
Item
participation in other clinical trials within one month before this trial
boolean
C2348568 (UMLS CUI [1])
individuals incapable of managing own affairs or not able to sign written consent
Item
individuals incapable of managing own affairs or not able to sign written consent
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
lack of written consent
Item
lack of written consent
boolean
C0021430 (UMLS CUI [1])
women of childbearing age not using reliable contraceptives
Item
women of childbearing age not using reliable contraceptives
boolean
C0009871 (UMLS CUI [1])
breast feeding women
Item
breast feeding women
boolean
C0006147 (UMLS CUI [1])